Standard Biotools | FLDM - Current Assets


Standard Biotools reported $521.45M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Danaher USD 14.79B 1.41B Sep/2026
Illumina USD 2.83B 96M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Nikon Corporation JPY 651.73B 5.23B Jun/2026
Pacific Biosciences Of California USD 338.64M 30.88M Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sony JPY 6.12T 172.51B Jun/2026
Standard Biotools USD 521.45M 67.19M Mar/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Waters USD 3.9B 186M Jun/2026